NCT00005839View on ClinicalTrials.gov

Oxaliplatin Plus Capecitabine in Treating Patients With Metastatic or Recurrent Solid Tumor

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 2000

Primary Completion Date

June 30, 2004

Study Completion Date

June 30, 2004

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

capecitabine

DRUG

oxaliplatin

Trial Locations (3)

91010

Beckman Research Institute, City of Hope, Los Angeles

95817

University of California Davis Cancer Center, Sacramento

90033-0800

USC/Norris Comprehensive Cancer Center, Los Angeles

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER

NCT00005839 - Oxaliplatin Plus Capecitabine in Treating Patients With Metastatic or Recurrent Solid Tumor | Biotech Hunter | Biotech Hunter